FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer's disease

Basel, 20 July 2018 FDA grants Breakthrough Device Designation for Roche’s Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer’s disease Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today, that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Elecsys® ß-Amyloid (1-42) CSF and Elecsys® Phospho-Tau (181P) CSF.... Read more

GE, Lagos State Government Sign Agreement on Power, Healthcare, Skills Development

Lagos, Nigeria – July 4, 2018: GE (NYSE: GE), the world’s premier digital industrial company and the Lagos State Government have agreed to pool their resources for the development of critical infrastructure in the state in the areas of Power, Healthcare and Skills Development. This was announced during the signing of a Support and Cooperation Agreement... Read more

AMETEK Grabner Instruments and Agilent Technologies Provide an Innovative Mobile Testing Solution for the Petroleum Industry

Wednesday, July 18, 2018 Vienna, Austria – AMETEK Grabner Instruments and Agilent Technologies Inc. announce an OEM agreement for an innovative mobile testing solution for in-the-field analysis of lubricating oils and greases. Grabner Instruments, based in Austria, is well known for developing and manufacturing automatic petroleum testing equipment. In this partnership, Grabner will focus on lube... Read more

Agilent and Grabner Instruments Provide Innovative Mobile Testing Solution for the Petroleum Industry

Agilent and Grabner Instruments Provide Innovative Mobile Testing Solution for the Petroleum Industry SANTA CLARA, Calif., July 18, 2018 Agilent Technologies Inc. (NYSE: A) announces an equipment manufacturing agreement with Grabner Instruments, a subsidiary of AMETEK, Inc. The agreement is focused on an innovative mobile testing solution for in-field analysis of lubricating oils and greases.... Read more

FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC)

Basel, 18 July 2018 FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC) Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab)... Read more

FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC)

Basel, 18 July 2018 FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC) Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab)... Read more

Teledyne CETAC Technologies Introduces the Next Generation Homogenizing Autosampler for Oils Applications

Introducing the next generation of automation for oils, wear oils and coolants for sample introduction for ICP-OES… The ‘Oils 7400’ Homogenizing Autosampler Omaha, NE USA / July 2, 2018 – Teledyne CETAC introduces the next generation homogenizing autosampler for oils, wear oils and coolants for sample introduction for ICP-OES.  The Oils 7400 Homogenizing Autosampler is... Read more

Agilent and Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis

Agilent and Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis Collaboration Will Focus on Persistent and Emerging Contaminants SANTA CLARA, Calif., July 9, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it will collaborate with the Nanyang Technological University, Singapore’s (NTU Singapore’s) Nanyang Environment Water Research Institute (NEWRI) to develop novel... Read more

FDA grants Priority Review to Roche’s baloxavir marboxil for the treatment of influenza

Basel, 26 June 2018 FDA grants Priority Review to Roche’s baloxavir marboxil for the treatment of influenza Influenza, or “flu,” represents a serious threat to public health – globally, annual epidemics result in 3 to 5 million cases of severe disease, millions of hospitalisations and up to 650,000 deaths worldwide1,2,3,4,5 If approved, baloxavir marboxil would... Read more

2018 Eppendorf Award for Young European Investigators presented to Andrea Ablasser

06/22, 2018 This year’s research prize awarded by Eppendorf AG goes to Switzerland Heidelberg/Hamburg, June 22, 2018 In 2018, the Hamburg life science company is presenting its highly prestigious research prize for the 23rd time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Andrea Ablasser, Assistant Professor at the Swiss... Read more